Abstract:Background and purpose:Pancreatic carcinoma is a kind of malignant disease with the rising tendency of incidence and poor prognosis.Little progress has been made on the treatment of advanced pancreatic carcinoma during the past 2 decades.The combined mordality for the unresectable pancreatic carcinoma is controversial.We retrospectively reviewed the clinical data and the results of transarterial intervention alone or transarterial intervention combined with radiotherapy,analyzed the prognostic factors for patients with unresectable pancreatic carcinoma.Methods:We retrospective analyzed 105 patients with locally advanced and metastatic pancreatic carcinoma.Univariate and multivariate statistical methods were used to determine significant prognostic factors and therapy program for overall survival(OS).Results:For all patients,the median survival time(MST) was 9.0 months,1-year and 2-year OS were 31.2% and 12.2% respectively.For the locally advanced vs phase Ⅳ patients,the MST,1-year,2-year OS were 9.1 vs 7.6 months,33.2% vs 29.3% and 14.7% vs 9.1% respectively.On univariate analysis,the number of interventional therapy,whether combined with radiotherapy or not,the choice of gemcitabine programs and primary tumor site were important factors for OS.For all 105 patients,the MST of patients who received multiple transarterial therapy was 4.9 months longer than those who had single therapy(12.5 vs 7.6 monthes,P=0.010).1-year and 2-year OS were 51.5% vs 22.2% and 20.7% vs 8.1%.The MST of patients who received combined therapy was 4.3 months longer compared with who had only interventional therapy(11.9 vs 7.6 monthes,P=0.003),1-year,2-year OS were 48.5% vs 21.8% and 27.7% vs 2.7%.The MST of patients who received gemcitabine programs was 2.2 months longer compared with who had other programs(9.8 vs 7.6 monthes,P=0.018),1-year,2-year OS were 37.5% vs 18.8% and 20.3% vs 3.1%.The MST of patients with pancreatic head cancer was 3.0 months longer compared with the patients whose cancer located in pancreatic body or tail(10.5 vs 7.5 monthes,P=0.031),1-year,2-year OS were 40.2% vs 22.0% and 6.3% vs 8.8%.On multivariate analysis,Interventional therapy combined radiotherapy was independent prognostic factor for OS,it could decrease death risk for all patients 46%(95%CI: 0.272-0.891,P=0.047).Conclusion:In the current study,transarterial intervention combined with radiotherapy can improve overall survival among patients with unresectable pancreatic cancer.

Concomitant Chemotherapy with Radiotherapy in Locally Advanced Pancreatic Cancer

Effect of Intensity Modulated Radiotherapy Combined with S-1-based Chemotherapy in Locally Advanced Gastric Cancer Patients.

Three-dimensional Conformal Radiotherapy in Combination with Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma.

Adjuvant Chemotherapy, with or Without Postoperative Radiotherapy, for Resectable Advanced Pancreatic Adenocarcinoma: Continue or Stop?

Induction Chemotherapy with Gemcitabine, Oxaliplatin, and 5-Fluorouracil/leucovorin Followed by Concomitant Chemoradiotherapy in Patients with Locally Advanced Pancreatic Cancer: a Taiwan Cooperative Oncology Group Phase II Study.

Three-dimensional Conformal Radiotherapy Combined with FOLFOX4 Chemotherapy for Unresectable Recurrent Rectal Cancer

A Meta-Analysis of Gemcitabine Containing Chemotherapy for Locally Advanced and Metastatic Pancreatic Adenocarcinoma

Three Dimensional-Conformal Radiotherapy Combined with Gemcitabine Chemotherapy for Locally Advanced Pancreatic Cancers

Outcome of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy for inoperable locally advanced pancreatic cancer

Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer

The multidisciplinary treatment of locally advanced pancreatic cancer

Consolidative Chemoradiotherapy after Induced Chemotherapy is an Optimal Regimen for Locally Advanced Pancreatic Cancer.

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer

Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer: Results of Feasibility Study

Results of Treatment of Patients with Advanced Pancreatic Carcinoma Treated by Intra-arterial Chemotherapy Combined with 3-D Conformal Radiotherapy

Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score-Matched Analysis.

Three dimensional-conformal radiotherapy combined with gemcitabine chemotherapy for locally advanced non-small cell lung cancer

Concurrent Chemotherapy and High Intensity Focused Ultrasound Treatment for Patients with Local Advanced Pancreatic Cancer or Metastatic Pancreatic Cancer: A Retrospective Study.

Percutaneous transhepatic cholangial drainage combined with intra-tumoral iodine-125 seeds implantation and chemotherapy for locally progressive pancreatic head cancer with obstructive jaundice

A retrospective analysis of patients with unresectable pancreatic cancer treated with combined transarterial intervention and three dimensional conformal radiotherapy

Combined modality therapy for stage II and stage III pancreatic carcinoma.